tirzepatide vs semaglutide weight loss efficacy versus Once Weekly in Patients with Type 2 Diabetes Semaglutide vs Tirzepatide for Weight

Using this cream may cause redness, itching, or swelling if you have sensitive skin

11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety and efficacy of the two highest investigational doses of retatrutide, a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity

The risk is related to the speed and magnitude of weight loss rather than a direct drug effect

Mechanistic comparison studies published pharmacological analyses confirm that Retatrutides GCGR activity produces statistically significant increases in resting energy expenditure versus dual agonists

MLOs do not establish distinct redox microenvironments but rather equilibrate with the surrounding redox conditions